ATE346170T1 - Verfahren zur diagnose von krebs - Google Patents

Verfahren zur diagnose von krebs

Info

Publication number
ATE346170T1
ATE346170T1 AT03024757T AT03024757T ATE346170T1 AT E346170 T1 ATE346170 T1 AT E346170T1 AT 03024757 T AT03024757 T AT 03024757T AT 03024757 T AT03024757 T AT 03024757T AT E346170 T1 ATE346170 T1 AT E346170T1
Authority
AT
Austria
Prior art keywords
diagnosis
cancer
plasm
prognosis
quantifying
Prior art date
Application number
AT03024757T
Other languages
English (en)
Inventor
Maurice Stroun
Philippe Anker
Original Assignee
Maurice Stroun
Philippe Anker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maurice Stroun, Philippe Anker filed Critical Maurice Stroun
Application granted granted Critical
Publication of ATE346170T1 publication Critical patent/ATE346170T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03024757T 2003-10-29 2003-10-29 Verfahren zur diagnose von krebs ATE346170T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03024757A EP1528107B1 (de) 2003-10-29 2003-10-29 Verfahren zur Diagnose von Krebs

Publications (1)

Publication Number Publication Date
ATE346170T1 true ATE346170T1 (de) 2006-12-15

Family

ID=34400483

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03024757T ATE346170T1 (de) 2003-10-29 2003-10-29 Verfahren zur diagnose von krebs

Country Status (3)

Country Link
EP (1) EP1528107B1 (de)
AT (1) ATE346170T1 (de)
DE (1) DE60309879D1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1997907A1 (de) 2007-06-01 2008-12-03 Friesland Brands B.V. Bifidobakterien
CN107267633A (zh) * 2017-07-20 2017-10-20 杭州更蓝生物科技有限公司 一种利用基因芯片检测结核分枝杆菌的方法
CN117660656B (zh) * 2024-02-01 2024-05-10 浙江省肿瘤医院 与胃癌预后相关的菌群标志物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329179B1 (en) * 1996-03-26 2001-12-11 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
EP1158055A1 (de) * 2000-05-26 2001-11-28 Xu Qi University of Teaxs Laboratoire de Leucémie Chen Verfahren zur Diagnose von Krebs
US6753137B2 (en) * 2001-01-31 2004-06-22 The Chinese University Of Hong Kong Circulating epstein-barr virus DNA in the serum of patients with gastric carcinoma

Also Published As

Publication number Publication date
DE60309879D1 (de) 2007-01-04
EP1528107A1 (de) 2005-05-04
EP1528107B1 (de) 2006-11-22

Similar Documents

Publication Publication Date Title
WO2006128192A3 (en) Use of free circulating dna for diagnosis, prognosis, and treatment of cancer
ATE275642T1 (de) Verfahren zur diagnose von krebs
WO2005040396A3 (en) qRT-PCR ASSAY SYSTEM FOR GENE EXPRESSION PROFILING
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
DE60237531D1 (de) Verfahren zum trennen von seltenen zellen von fluidproben
BRPI0607508B8 (pt) método para detecção e/ou classificação de distúrbios proliferativos celulares colorretais ou hepatocelulares, e uso do mesmo
DE60239470D1 (de) Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
WO2006036744A3 (en) Methods for a global assay of coagulation and fibrinolysis
HK1086331A1 (en) Compounds and methods for detection of carcinomas and their precursor lesions
ATE429495T1 (de) Nukleinsäuren für die apoptose von krebszellen
ATE486285T1 (de) Verfahren zur früherkennung von krebs
WO2004029285A3 (en) Methods for detecting endocrine cancer
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE50104561D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
WO2004109286A3 (en) Methods for detecting and treating cancer using podocalyxin and/or endoglycan
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8
ATE494556T1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
ATE346170T1 (de) Verfahren zur diagnose von krebs
ATE494390T1 (de) Verfahren und nukleinsäuren zur analyse von störungen der proliferation von kolonzellen
WO2005091750A3 (en) Method and materials for use in diagnosing viral myocarditis
ATE429440T1 (de) Formen prostataspezifischer antigene und verfahren zu deren nachweis
DE60329224D1 (de) Verfahren zur Bestimmung von zirkulierender DNS in Plasma und zum Nachweis von Krebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties